marketcaparena
Search

    ICCC

    IMMUCELL CORP /DE/

    Company overview

    Market capitalization
    $89.73M
    Employees
    73
    Latest publication
    2026-09-29
    About IMMUCELL CORP /DE/

    ImmuCell Corporation, an animal health company, develops, manufactures, and sells products that improves the health and productivity of dairy and beef cattle in the United States and internationally. It operates through two segments, Scours and Mastitis. The company offers First Defense, an orally delivered scours preventive product for calves with claims against E. coli, coronavirus, and rotavirus; and Tri-Shield First Defense, a passive antibody product for the treatment of E. coli, coronavirus, and rotavirus. It also provides California Mastitis Test, a quick on-farm diagnostic that is used to detect somatic cell counts in milk, as well as to determine, which quarter of the udder is mastitic; and Dual-Force First Defense, a bivalent gel tube formulation. In addition, the company developing Re-Tain Drug Product, a Nisin-based intramammary treatment of subclinical mastitis in lactating dairy cows. It sells its products through animal health distributors. ImmuCell Corporation was incorporated in 1982 and is based in Portland, Maine.

    Company website

    Financial statements

    Income Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USDQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USD
    Total Revenue7,186,113USD10,357,295USD7,625,999USD5,506,122USD6,444,880USD8,067,174USD7,751,129USD6,011,573USD
    Cost Of Revenue4,748,891USD5,699,851USD4,715,790USD3,143,024USD3,626,956USD4,713,202USD4,919,483USD4,428,019USD
    Gross Profit2,437,222USD4,657,444USD2,910,209USD2,363,098USD2,817,924USD3,353,972USD2,831,646USD1,583,554USD
    Research Development119,652USD317,688USD758,864USD694,311USD831,858USD756,847USD819,393USD786,136USD
    Selling General Administrative1,271,909USD2,370,440USD1,127,961USD729,421USD720,418USD1,479,501USD554,711USD528,267USD
    Selling And Marketing Expenses1,110,727USD—1,081,340USD919,291USD696,086USD856,658USD836,147USD844,045USD
    General And Administrative Expenses1,271,909USD———————
    Total Operating Expenses502,288USD2,688,128USD2,968,165USD2,343,023USD2,248,362USD6,949,550USD2,210,251USD2,158,448USD
    Operating Income1,934,934USD1,969,316USD-57,956USD20,075USD569,562USD1,117,624USD621,395USD-574,894USD
    Total Other Income Expense Net-54,328USD-15,187USD-2,787,880USD-155,367USD-65,778USD421,722USD-100,804USD574,193USD
    Interest Income65,343USD44,367USD31,659USD41,468USD48,113USD37,469USD36,226USD18,685USD
    Interest Expense95,667USD99,675USD102,988USD134,516USD124,795USD117,122USD125,389USD133,336USD
    Income Before Tax1,880,606USD1,954,129USD-2,845,836USD-135,292USD503,784USD1,448,887USD520,591USD-700,350USD
    Income Tax Expense45,950USD12,522USD3,306USD4,456USD1,904USD1,904USD6,036USD1,340USD
    Net Income1,834,656USD1,941,607USD-2,849,142USD-139,748USD501,880USD1,446,983USD514,555USD-701,690USD
    Net Income Applicable To Common Shares1,834,656USD———————
    Net Interest Income—-55,308USD-74,486USD-93,048USD-76,682USD-90,459USD-99,970USD-125,456USD
    Tax Provision—12,522USD3,306USD4,456USD1,904USD1,904USD6,036USD1,340USD
    Net Income From Continuing Ops—1,941,607USD-2,849,142USD-139,748USD501,880USD1,446,983USD514,555USD-701,690USD
    Ebit—1,969,316USD-2,742,848USD-135,292USD628,579USD1,117,624USD645,980USD-574,894USD
    Ebitda—2,497,610USD-2,036,533USD543,798USD1,296,810USD1,793,591USD1,319,828USD100,228USD
    Depreciation And Amortization—528,294USD706,315USD679,090USD668,231USD675,967USD673,848USD675,122USD
    Reconciled Depreciation—528,294USD706,315USD679,088USD668,231USD675,967USD673,848USD675,122USD
    Unclassified Operating Expenses—————3,856,544USD——
    SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Income Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
    Total Revenue27,644,174USD26,493,169USD17,471,669USD18,568,000USD19,242,969USD15,342,000USD13,723,000USD10,986,000USD
    Cost Of Revenue16,198,971USD18,552,125USD13,075,385USD10,919,000USD10,587,040USD8,479,000USD6,983,000USD5,792,000USD
    Gross Profit11,445,203USD7,941,044USD4,396,284USD7,649,000USD8,655,929USD6,863,000USD6,740,000USD5,194,000USD
    Research Development3,041,880USD3,898,582USD4,394,852USD4,494,000USD4,168,518USD4,354,000USD3,688,000USD3,517,000USD
    Selling General Administrative3,200,643USD2,216,549USD2,134,295USD2,263,817USD1,726,100USD1,720,653USD1,687,907USD1,738,953USD
    Selling And Marketing Expenses3,553,375USD3,466,072USD3,088,215USD—2,503,926USD——2,084,903USD
    Total Operating Expenses9,795,898USD9,581,203USD10,144,362USD9,948,000USD8,398,544USD8,243,000USD7,694,000USD7,341,000USD
    Operating Income1,649,305USD-1,640,159USD-5,748,078USD-2,299,000USD257,385USD-1,380,000USD-954,000USD-1,447,000USD
    Interest Income158,709USD77,702USD143,850USD153,100USD18,810USD27,440USD118,283USD14,301USD
    Interest Expense439,036USD568,725USD402,385USD340,878USD314,359USD412,687USD431,788USD427,782USD
    Net Interest Income-334,675USD-491,023USD-272,979USD-195,436USD-295,549USD-385,247USD-313,505USD-413,481USD
    Income Before Tax-1,028,457USD-2,146,573USD-5,769,971USD-2,486,000USD-69,127USD-1,032,000USD-1,268,000USD-1,860,000USD
    Income Tax Expense11,570USD10,056USD4,627USD8,000USD9,165USD-10,000USD28,000USD462,000USD
    Tax Provision11,570USD10,056USD4,789USD8,000USD9,000USD-10,000USD28,174USD461,620USD
    Net Income-1,040,027USD-2,156,629USD-5,774,598USD-2,494,000USD-78,292USD-1,022,000USD-1,296,000USD-2,322,000USD
    Net Income From Continuing Ops-1,040,027USD-2,156,629USD-6,302,633USD-2,494,000USD-78,000USD-1,022,000USD-1,295,587USD-2,321,671USD
    Ebit-589,421USD-1,620,514USD-5,221,077USD-2,299,000USD237,391USD-1,380,000USD-954,000USD-1,432,269USD
    Ebitda2,140,180USD1,066,667USD-2,504,077USD188,583USD2,698,531USD967,283USD1,313,421USD88,442USD
    Depreciation And Amortization2,729,601USD2,687,181USD2,717,000USD2,487,583USD2,461,140USD2,347,283USD2,267,421USD1,520,711USD
    Reconciled Depreciation2,729,601USD2,687,181USD2,646,371USD2,487,583USD2,461,140USD2,347,283USD2,267,421USD1,520,711USD
    Total Other Income Expense Net-2,677,762USD-506,414USD-21,893USD-187,000USD-326,512USD348,000USD-314,000USD-413,481USD
    Unclassified Operating Expenses———3,190,183USD—2,168,347USD2,318,093USD—
    Net Income Applicable To Common Shares———-2,493,805,000USD-78,000USD-1,022,000USD-1,295,587USD-2,321,671USD
    Non Operating Income Net Other—————348,100USD-313,505USD-413,481USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USDQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USD
    Total Assets46,629,796USD44,108,374USD42,532,000USD45,730,123USD46,720,898USD45,621,579USD45,100,477USD44,448,873USD
    Cash And Equivalents8,860,205USD———————
    Total Current Assets21,080,036USD18,862,022USD16,944,882USD16,825,178USD17,136,309USD15,919,639USD15,042,750USD13,887,486USD
    Other Current Assets244,084USD681,215USD451,873USD527,868USD419,653USD560,096USD360,207USD277,146USD
    Other Non Current Assets31,658USD———————
    Total Liabilities15,255,260USD———————
    Total Current Liabilities4,435,802USD3,913,076USD3,978,257USD3,997,888USD4,446,415USD3,865,753USD4,412,213USD4,465,837USD
    Total Stockholder Equity31,374,536USD29,135,040USD27,055,480USD29,800,841USD29,867,428USD28,993,844USD27,518,187USD26,411,671USD
    Total Equity Including Noncontrolling Interest31,374,536USD———————
    Short Long Term Debt1,506,219USD1,628,540USD1,610,185USD1,591,836USD1,535,439USD1,516,230USD1,497,619USD1,479,058USD
    Long Term Debt6,796,667USD7,073,726USD7,488,922USD7,898,714USD8,263,223USD8,653,064USD9,040,975USD9,422,961USD
    Net Receivables2,897,281USD2,694,418USD3,419,009USD2,609,107USD2,423,736USD3,402,806USD3,811,688USD2,341,255USD
    Inventory9,078,466USD8,673,752USD9,267,000USD9,802,005USD8,294,426USD7,357,366USD7,112,623USD7,460,452USD
    Property Plant Equipment Net25,422,545USD25,116,641USD25,454,322USD28,760,267USD29,425,861USD29,546,638USD29,909,698USD30,413,051USD
    Goodwill95,557USD———————
    Accounts Payable892,783USD998,496USD796,286USD972,144USD1,304,993USD986,111USD943,637USD883,214USD
    Short Term Debt121,858USD1,717,126USD1,695,674USD1,674,278USD1,858,192USD1,897,188USD1,929,691USD1,961,302USD
    Common Stock910,563USD910,563USD910,563USD910,563USD910,563USD904,593USD904,240USD889,641USD
    Retained Earnings-11,427,490USD-13,262,146USD-15,203,753USD-12,354,611USD-12,214,863USD-12,716,743USD-14,163,726USD-14,678,281USD
    Total Liab—14,973,334USD15,476,967USD15,929,282USD16,853,470USD16,627,735USD17,582,290USD18,037,202USD
    Other Current Liab—1,197,454USD1,486,297USD1,351,466USD1,283,230USD982,454USD1,533,070USD1,620,155USD
    Capital Stock—910,563USD910,563USD910,563USD910,563USD904,593USD904,240USD889,641USD
    Good Will—95,557USD95,557USD95,557USD95,557USD95,557USD95,557USD95,557USD
    Cash—6,812,637USD3,807,000USD3,886,198USD5,998,494USD4,599,371USD3,758,232USD3,808,633USD
    Cash And Short Term Investments—6,812,637USD3,807,000USD3,886,198USD5,998,494USD4,599,371USD3,758,232USD3,808,633USD
    Net Debt—5,964,747USD9,387,384USD9,719,474USD8,266,753USD10,059,799USD11,341,536USD11,724,034USD
    Short Long Term Debt Total—12,777,384USD13,194,384USD13,605,672USD14,265,247USD14,659,170USD15,099,768USD15,532,667USD
    Property Plant Equipment Gross—25,116,641USD44,291,946USD50,359,367USD51,692,622USD51,227,758USD50,951,249USD50,794,247USD
    Common Stock Shares Outstanding—9,045,977shares9,046,000shares9,046,000shares9,031,282shares8,980,602shares8,935,000shares8,164,423shares
    Non Current Assets Total—25,246,352USD25,587,565USD28,904,944USD29,584,589USD29,701,940USD30,057,727USD30,561,387,000USD
    Non Current Liabilities Total—11,060,258USD11,498,710USD11,931,394USD12,407,055USD12,761,982USD13,170,077USD13,571,365USD
    Non Currrent Assets Other—34,154USD25,492,008USD44,344USD53,619USD45,417USD33,368USD30,530,854,512USD
    Net Working Capital—14,948,946USD12,966,625USD12,827,290USD12,689,894USD12,053,886USD10,630,537USD9,421,649USD
    Unclassified Current Liabilities—-1,628,540USD-1,610,185USD-1,591,836USD-1,535,439USD-1,516,230USD-1,491,804USD-1,477,892USD
    Unclassified Non Current Liabilities—3,986,532USD4,009,788USD4,032,680USD4,143,832USD4,108,918USD4,129,102USD4,148,404USD
    Unclassified Equity—40,576,060USD40,438,107USD40,334,326USD40,261,165USD39,901,401USD13,461,762USD39,310,670USD
    Other Assets——29,458,000USD———11,234,117USD-30,530,825,613USD
    Unclassified Non Current Assets——-54,912,322USD———-11,234,117USD—
    Intangible Assets———4,776USD9,552USD14,328USD19,104USD23,880USD
    Short Term Investments——————50,401USD—
    Accumulated Other Comprehensive Income——————26,411,671USD—
    SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
    Total Assets42,532,000USD45,100,477USD43,808,102USD44,861,000USD44,466,000USD40,350,000USD38,691,836USD32,731,000USD
    Other Current Assets451,873USD360,207USD493,885USD363,877USD268,713USD253,640USD219,032USD142,528USD
    Total Liab15,476,967USD17,582,290USD18,815,025USD14,481,000USD11,889,000USD12,084,000USD9,700,558USD10,987,000USD
    Total Stockholder Equity27,055,480USD27,518,187USD24,993,077USD30,380,000USD32,577,000USD28,266,000USD28,991,278USD21,744,000USD
    Other Current Liab1,486,297USD1,538,885USD1,249,780USD1,205,975USD867,065USD747,880USD648,388USD616,917USD
    Common Stock910,563USD904,240USD781,417USD781,417USD781,417USD729,901USD729,901USD566,265USD
    Capital Stock910,563USD904,240USD781,417USD781,417USD781,417USD729,901USD729,901USD566,265USD
    Retained Earnings-15,203,753USD-14,163,726USD-12,007,097USD-6,232,499USD-3,738,694USD-3,660,402USD-2,638,285USD-1,342,698USD
    Good Will95,557USD95,557USD95,557USD95,557USD95,557USD95,557USD95,557USD95,557USD
    Other Assets29,458,000USD—1USD351USD312USD406USD164USD168USD
    Cash3,807,000USD3,758,232USD978,741USD5,792,000USD10,185,468USD7,946,000USD6,293,293USD2,521,000USD
    Cash And Short Term Investments3,807,000USD3,758,232USD978,741USD5,792,000USD10,185,000USD7,946,000USD8,774,046USD2,521,000USD
    Total Current Assets16,944,882USD15,042,750USD11,469,850USD13,994,756USD16,264,868USD12,157,008USD13,189,033USD6,420,836USD
    Total Current Liabilities3,978,257USD4,412,213USD4,197,420USD3,072,073USD2,534,469USD2,211,076USD2,495,356USD2,565,011USD
    Net Debt9,387,384USD11,341,536USD15,711,947USD6,687,738USD89,030USD2,787,167USD2,128,173USD7,244,838USD
    Short Term Debt1,695,674USD1,929,691USD2,073,083USD1,071,211USD920,219USD860,849USD1,274,790USD1,344,351USD
    Short Long Term Debt1,610,185USD1,497,619USD1,428,807USD1,039,447USD812,207USD760,337USD1,274,790USD1,344,351USD
    Short Long Term Debt Total13,194,384USD15,099,768USD16,690,688USD12,479,738USD10,274,498USD10,733,167USD8,421,466USD9,765,838USD
    Long Term Debt7,488,922USD9,040,975USD10,540,496USD9,191,109USD8,327,122USD8,737,149USD7,146,676USD8,421,487USD
    Net Receivables3,419,009USD3,811,688USD2,185,383USD1,800,778USD2,720,713USD1,864,422USD1,677,699USD1,425,587USD
    Inventory9,267,000USD7,112,623USD7,811,841USD6,038,539USD3,089,974USD2,092,514USD2,518,256USD2,331,671USD
    Accounts Payable796,286USD943,637USD887,733USD789,997USD745,044USD602,347USD572,178USD603,743USD
    Property Plant Equipment Net25,454,322USD29,909,698USD32,146,832USD30,636,396USD28,002,732USD27,975,336USD25,265,738USD26,027,549USD
    Property Plant Equipment Gross44,291,946USD50,951,249USD50,630,780USD46,512,016USD41,996,005USD26,754,975USD25,265,738USD26,027,549USD
    Common Stock Shares Outstanding9,026,000shares8,167,000shares7,747,686shares7,745,122shares7,592,290shares7,213,329shares6,818,960shares5,486,000shares
    Non Current Assets Total25,587,565USD30,057,727USD32,338,252USD30,865,893USD28,200,820USD28,192,586USD25,502,803USD26,309,996USD
    Non Current Liabilities Total11,498,710USD13,170,077USD14,617,605USD11,408,527USD9,354,279USD9,872,318USD7,205,201USD8,421,487USD
    Non Currrent Assets Other25,492,008USD33,368USD57,655USD76,628USD26,115USD26,173USD26,884USD53,162USD
    Net Working Capital12,966,625USD10,630,537USD7,272,430USD10,922,683USD13,730,399USD9,945,932USD10,693,677USD3,855,825USD
    Unclassified Non Current Assets-54,912,322USD———————
    Unclassified Current Liabilities-1,610,185USD-1,497,619USD-1,732,537USD-1,034,557USD——-1,274,790USD-1,344,351USD
    Unclassified Non Current Liabilities4,009,788USD4,129,102USD4,077,109USD2,217,418USD1,027,157USD———
    Unclassified Equity40,438,107USD13,461,762USD35,437,340USD35,049,665USD34,752,860USD30,641,992USD30,401,992USD22,128,958USD
    Intangible Assets—19,104USD38,208USD57,312USD76,416USD95,520USD114,624USD133,728USD
    Accumulated Other Comprehensive Income—26,411,671USD0USD0USD0USD—-43,895USD30,157USD
    Current Deferred Revenue——290,554USD—————
    Net Tangible Assets———30,227,180,000USD32,285,126USD27,824,808USD28,781,097USD21,515,049USD
    Short Term Investments————-468USD996,495USD2,480,753USD—
    Treasury Stock—————-175,392USD-188,336USD-204,947USD
    Non Current Liabilities Other—————1,135,169USD——
    Deferred Long Term Liab——————58,526USD—
    Long Term Investments———————40,209USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow YTD

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USD
    Depreciation998,915USD
    Stock Based Compensation377,816USD
    Change To Account Receivables521,728USD
    Change To Inventory188,903USD
    Change To Liabilities472,701USD
    Change In Working Capital1,396,949USD
    Operating Cash Flow6,592,102USD
    Capital Expenditures-911,169USD
    Unclassified Investing Cash Flow10,000USD
    Investing Cash Flow-901,169USD
    Net Debt Issuance-802,536USD
    Unclassified Financing Cash Flow164,977USD
    Financing Cash Flow-637,559USD
    Change In Cash5,053,374USD
    End Cash Flow8,860,205USD
    SourceDisclosureDeterministicFinal

    Cash flow Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USDQ2 20242024-06-30 · USD
    Net Income1,941,607USD-2,849,142USD-139,748USD501,880USD1,446,983USD515,000USD-701,690USD-1,531,626USD
    Depreciation528,294USD706,315USD679,088USD668,231USD675,967USD685,000USD675,122USD670,958USD
    Stock Based Compensation137,949USD103,781USD73,161USD66,714USD52,215USD68,863USD77,557USD98,021USD
    Other Non Cash Items18,948USD2,736,605USD-136,229USD-35,097USD-22,327USD-37,391USD-26,630USD-12,072USD
    Change To Account Receivables724,591USD-864,243USD-175,943USD967,602USD424,708USD-1,463,220USD-357,463USD672,082USD
    Change To Inventory593,617USD534,636USD-1,507,579USD-937,060USD-244,743USD347,829USD-160,846USD-150,043USD
    Change In Working Capital946,233USD-215,018USD-1,658,855USD399,770USD-579,000USD-1,234,523USD-663,690USD1,356,499USD
    Total Cash From Operating Activities3,573,031USD482,541USD-1,182,583USD1,601,498USD1,573,836USD-3,051USD-639,331USD581,780USD
    Capital Expenditures-177,230USD-172,306USD-593,924USD-155,159USD-329,050USD-196,218USD-88,412USD-110,741USD
    Free Cash Flow3,395,801USD310,235USD-1,776,507USD1,446,339USD1,244,786USD-199,267USD-727,743USD471,039USD
    Total Cashflows From Investing Activities-167,230USD-167,306USD-592,024USD-125,927USD-329,050USD-196,216USD-88,412USD-106,241USD
    Net Borrowings-399,999USD-394,602USD-323,056USD-381,438USD-380,106USD-374,232USD-368,250USD—
    Total Cash From Financing Activities-399,995USD-394,602USD-337,689USD-76,448USD-403,647USD148,866USD3,212,091USD-111,601USD
    Issuance Of Capital Stock0USD0USD0USD329,892USD19,434USD814,932USD3,580,341USD252,749USD
    Change In Cash3,005,806USD-79,367USD-2,112,296USD1,399,123USD841,139USD-50,401USD2,484,348USD363,938USD
    Begin Period Cash Flow3,807,000USD3,886,198USD5,998,494USD4,599,371USD3,758,232USD3,808,633USD1,324,285USD960,347USD
    End Period Cash Flow6,812,637USD3,806,831USD3,886,198USD5,998,494USD4,599,371USD3,758,232USD3,808,633USD1,324,285USD
    Other Cashflows From Investing Activities10,000USD5,000USD1,900USD————4,500USD
    Other Cashflows From Financing Activities-399,995USD-1,144,123USD—-24,902USD-42,975USD-291,834USD-88,412USD252,749USD
    Unclassified Financing Cash Flow—1,144,123USD——————
    Investments——-592,024USD-125,927USD-329,050USD-196,216USD-88,412USD-106,241USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
    Net Income-1,040,027USD-2,157,000USD-5,774,598USD-2,493,805USD-78,292USD-1,022,117USD-1,295,587USD-2,321,671USD
    Depreciation2,729,601USD2,687,181USD2,717,001USD2,487,583USD2,461,140USD2,347,283USD2,267,421USD1,520,711USD
    Stock Based Compensation295,871USD326,000USD368,866USD266,244USD144,313USD253,135USD313,144USD344,016USD
    Other Non Cash Items2,542,952USD-91,762USD260,818USD28,800USD18,557USD-780,353USD19,445USD-681,438USD
    Change To Account Receivables352,124USD-1,585,750USD-426,783USD935,629USD-897,428USD-159,636USD-704,867USD411,724USD
    Change To Inventory-2,154,746USD699,218USD-1,773,302USD-2,948,565USD-997,460USD425,742USD-186,585USD-281,939USD
    Change In Working Capital-2,053,105USD-406,516USD-2,268,942USD-1,832,693USD-1,622,511USD532,261USD-1,095,596USD302,663USD
    Total Cash From Operating Activities2,475,292USD357,903USD-4,674,236USD-1,543,871USD954,170USD1,315,578USD233,511USD-373,404USD
    Capital Expenditures-1,250,439USD-465,725USD-1,892,513USD-3,975,274USD-2,608,649USD-4,072,539USD-1,391,446USD-2,029,895USD
    Free Cash Flow1,224,853USD-107,822USD-6,566,749USD-5,519,145USD-1,654,479USD-2,756,961USD-1,157,935USD-2,403,299USD
    Total Cashflows From Investing Activities-1,214,307USD-461,225USD-1,890,039USD-3,964,274USD-1,597,359USD-2,569,939USD-3,403,360USD-1,793,972USD
    Net Borrowings-1,479,202USD-1,468,338USD1,814,226USD1,102,875,000USD-368,271USD1,964,132USD-1,361,347USD793,361USD
    Total Cash From Financing Activities-1,212,386USD2,882,813USD1,751,454USD1,114,239USD3,878,720USD1,911,005USD6,942,092USD889,615USD
    Issuance Of Capital Stock349,326USD4,648,022USD0USD0USD4,233,026USD4,233,026USD8,303,436USD0USD
    Change In Cash48,599USD2,779,491USD-4,812,821USD-4,393,906USD3,235,531USD656,644USD3,772,243USD-1,277,761USD
    Begin Period Cash Flow3,758,232USD978,741USD5,791,562USD10,185,468USD6,949,937USD6,293,293USD2,521,050USD3,798,811USD
    End Period Cash Flow3,806,831USD3,758,232USD978,741USD5,791,562USD10,185,468USD6,949,937USD6,293,293USD2,521,050USD
    Other Cashflows From Investing Activities36,132USD4,500USD2,474USD11,000USD15,290USD45,600USD450,000USD250,000USD
    Other Cashflows From Financing Activities-82,513USD-5,037USD-62,772USD11,364USD13,965USD-53,127USD8,303,439USD94,283USD
    Investments—-461,225USD-3,414,001USD-3,964,274USD-1,597,359USD-2,569,939USD-2,003,000USD250,000USD
    Unclassified Investing Cash Flow——3,414,001USD3,964,274USD2,593,359USD4,026,939USD——
    Change To Liabilities———341,614,000USD245,760USD299,881USD-88,711USD56,062USD
    Unclassified Financing Cash Flow———-1,101,772,125USD——-8,303,439USD—
    Sale Purchase Of Stock—————9USD8,303,439USD96,254USD
    Cash And Cash Equivalents Changes—————656,644USD3,772,243USD-1,277,761USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Operating metrics

    No operating metrics are currently published for this company.

    Revenue breakdown

    PeriodDimensionBusiness / regionRevenueCurrencySource
    Q1 2026Quarterly · 2026-03-31GeographyAmericas9,734,045USD0001437749-26-017045
    Q1 2026Quarterly · 2026-03-31GeographyInternational623,250USD0001437749-26-017045
    Q1 2026Quarterly · 2026-03-31SegmentCorporate Segment Mastitis49,520USD0001437749-26-017045
    Q1 2026Quarterly · 2026-03-31SegmentCorporate Segment Scours10,307,775USD0001437749-26-017045
    FY 2025Yearly · 2025-12-31GeographyAmericas24,391,664USD0001437749-26-010339
    FY 2025Yearly · 2025-12-31GeographyInternational3,252,510USD0001437749-26-010339
    FY 2025Yearly · 2025-12-31SegmentCorporate Segment Mastitis196,388USD0001437749-26-010339
    FY 2025Yearly · 2025-12-31SegmentCorporate Segment Scours27,447,786USD0001437749-26-010339
    Q3 2025Quarterly · 2025-09-30GeographyAmericas5,336,009USD0001437749-25-034817
    Q3 2025Quarterly · 2025-09-30GeographyInternational170,113USD0001437749-25-034817
    Q3 2025Quarterly · 2025-09-30SegmentCorporate Segment Mastitis61,503USD0001437749-25-034817
    Q3 2025Quarterly · 2025-09-30SegmentCorporate Segment Scours5,444,619USD0001437749-25-034817
    Q3 2025Quarterly · 2025-09-30ProductProduct5,444,619USD0001437749-25-034817
    Q3 2025Quarterly · 2025-09-30ProductProduct And Service Other61,503USD0001437749-25-034817
    Q2 2025Quarterly · 2025-06-30GeographyOther States1,570,319USD0001213900-25-076635
    Q2 2025Quarterly · 2025-06-30GeographyUnited States4,874,561USD0001213900-25-076635
    Q2 2025Quarterly · 2025-06-30SegmentMastitis46,363USD0001213900-25-076635
    Q2 2025Quarterly · 2025-06-30SegmentScours6,398,517USD0001213900-25-076635
    Q2 2025Quarterly · 2025-06-30ProductFirst Defense Product Line6,398,517USD0001213900-25-076635
    Q2 2025Quarterly · 2025-06-30ProductOther Animal Health46,363USD0001213900-25-076635
    Q1 2025Quarterly · 2025-03-31GeographyAmericas7,174,890USD0001437749-26-017045
    Q1 2025Quarterly · 2025-03-31GeographyInternational892,284USD0001437749-26-017045
    Q1 2025Quarterly · 2025-03-31SegmentCorporate Segment Mastitis38,688USD0001437749-26-017045
    Q1 2025Quarterly · 2025-03-31SegmentCorporate Segment Scours8,028,486USD0001437749-26-017045
    Q1 2025Quarterly · 2025-03-31ProductFirst Defense Product Line8,028,486USD0001213900-25-043287
    Q1 2025Quarterly · 2025-03-31ProductOther Animal Health38,688USD0001213900-25-043287
    Q4 2024Quarterly · 2024-12-31GeographyOther States1,306,586USDLegacy provider
    Q4 2024Quarterly · 2024-12-31GeographyUnited States6,444,543USDLegacy provider
    Q4 2024Quarterly · 2024-12-31SegmentMastitis38,932USDLegacy provider
    Q4 2024Quarterly · 2024-12-31SegmentScours7,712,197USDLegacy provider
    FY 2024Yearly · 2024-12-31GeographyAmericas22,893,721USD0001437749-26-010339
    FY 2024Yearly · 2024-12-31GeographyInternational3,599,448USD0001437749-26-010339
    FY 2024Yearly · 2024-12-31SegmentCorporate Segment Mastitis178,918USD0001437749-26-010339
    FY 2024Yearly · 2024-12-31SegmentCorporate Segment Scours26,314,251USD0001437749-26-010339
    Q4 2024Quarterly · 2024-12-31ProductFirst Defense Product Line7,712,196USDLegacy provider
    Q4 2024Quarterly · 2024-12-31ProductOther Animal Health38,933USDLegacy provider
    FY 2024Yearly · 2024-12-31ProductFirst Defense Product Line26,314,250USD0001013762-25-004072
    FY 2024Yearly · 2024-12-31ProductOther Animal Health178,919USD0001013762-25-004072
    Q3 2024Quarterly · 2024-09-30GeographyAmericas5,216,401USD0001437749-25-034817
    Q3 2024Quarterly · 2024-09-30GeographyInternational795,172USD0001437749-25-034817
    Q3 2024Quarterly · 2024-09-30SegmentCorporate Segment Mastitis60,229USD0001437749-25-034817
    Q3 2024Quarterly · 2024-09-30SegmentCorporate Segment Scours5,951,344USD0001437749-25-034817
    Q3 2024Quarterly · 2024-09-30ProductFirst Defense Product Line5,951,344USD0001213900-24-097450
    Q3 2024Quarterly · 2024-09-30ProductOther Animal Health60,229USD0001213900-24-097450
    Q2 2024Quarterly · 2024-06-30GeographyOther States580,754USD0001213900-25-076635
    Q2 2024Quarterly · 2024-06-30GeographyUnited States4,892,136USD0001213900-25-076635
    Q2 2024Quarterly · 2024-06-30SegmentMastitis42,821USD0001213900-25-076635
    Q2 2024Quarterly · 2024-06-30SegmentScours5,430,069USD0001213900-25-076635
    Q2 2024Quarterly · 2024-06-30ProductProduct5,951,344USD0001437749-25-034817
    Q2 2024Quarterly · 2024-06-30ProductProduct And Service Other60,229USD0001437749-25-034817
    Q1 2024Quarterly · 2024-03-31GeographyOther States916,936USD0001213900-25-043287
    Q1 2024Quarterly · 2024-03-31GeographyUnited States6,340,641USD0001213900-25-043287
    Q1 2024Quarterly · 2024-03-31SegmentMastitis36,936USD0001213900-25-043287
    Q1 2024Quarterly · 2024-03-31SegmentScours7,220,641USD0001213900-25-043287
    Q1 2024Quarterly · 2024-03-31ProductFirst Defense Product Line7,220,641USD0001213900-25-043287
    Q1 2024Quarterly · 2024-03-31ProductOther Animal Health36,936USD0001213900-25-043287
    FY 2023Yearly · 2023-12-31GeographyOther States1,522,287USD0001013762-25-004072
    FY 2023Yearly · 2023-12-31GeographyUnited States15,949,382USD0001013762-25-004072
    FY 2023Yearly · 2023-12-31SegmentMastitis177,736USD0001013762-25-004072
    FY 2023Yearly · 2023-12-31SegmentScours17,293,933USD0001013762-25-004072
    Q4 2023Quarterly · 2023-12-31ProductFirst Defense Product Line5,040,379USDLegacy provider
    Q4 2023Quarterly · 2023-12-31ProductOther Animal Health55,582USDLegacy provider
    FY 2023Yearly · 2023-12-31ProductFirst Defense Product Line17,293,933USD0001013762-25-004072
    FY 2023Yearly · 2023-12-31ProductOther Animal Health177,736USD0001013762-25-004072
    FY 2022Yearly · 2022-12-31GeographyOther States1,547,165USD0001213900-24-028718
    FY 2022Yearly · 2022-12-31GeographyUnited States17,020,797USD0001213900-24-028718
    FY 2022Yearly · 2022-12-31SegmentAll Other Segments1,455USD0001213900-24-097450
    FY 2022Yearly · 2022-12-31SegmentMastitis154,558USD0001213900-24-097450
    FY 2022Yearly · 2022-12-31SegmentScours18,411,949USD0001213900-24-097450
    FY 2022Yearly · 2022-12-31ProductFirst Defense Product Line18,411,949USD0001213900-24-028718
    FY 2022Yearly · 2022-12-31ProductOther Animal Health156,013USD0001213900-24-028718
    FY 2021Yearly · 2021-12-31GeographyOther States2,622,606USD0001213900-23-086092
    FY 2021Yearly · 2021-12-31GeographyUnited States16,620,363USD0001213900-23-086092
    FY 2021Yearly · 2021-12-31SegmentAll Other Segments166,597USD0001213900-23-086092
    FY 2021Yearly · 2021-12-31SegmentMastitis143,280USD0001213900-23-086092
    FY 2021Yearly · 2021-12-31SegmentScours18,933,092USD0001213900-23-086092
    FY 2021Yearly · 2021-12-31ProductFirst Defense Product Line18,933,092USD0001213900-23-086092
    FY 2021Yearly · 2021-12-31ProductOther Animal Health309,877USD0001213900-23-086092
    FY 2020Yearly · 2020-12-31GeographyOther States1,697,436USD0001213900-22-016147
    FY 2020Yearly · 2020-12-31GeographyUnited States13,644,768USD0001213900-22-016147
    FY 2020Yearly · 2020-12-31SegmentFirst Defense15,072,446USD0001213900-22-016147
    FY 2020Yearly · 2020-12-31SegmentUnallocated269,758USD0001213900-22-016147
    FY 2020Yearly · 2020-12-31ProductFirst Defense Product Line15,072,446USD0001213900-22-074215
    FY 2020Yearly · 2020-12-31ProductOther Animal Health269,758USD0001213900-22-074215
    FY 2019Yearly · 2019-12-31GeographyOther States1,531,764USD0001213900-21-026068
    FY 2019Yearly · 2019-12-31GeographyUnited States12,191,108USD0001213900-21-026068
    FY 2019Yearly · 2019-12-31ProductFirst Defense Product Line13,244,396USD0001213900-21-026068
    FY 2019Yearly · 2019-12-31ProductOther Animal Health344,875USD0001213900-21-026068
    FY 2019Yearly · 2019-12-31ProductOther Product Services133,601USD0001213900-21-026068
    FY 2018Yearly · 2018-12-31GeographyOther States1,427,155USD0001213900-20-007650
    FY 2018Yearly · 2018-12-31GeographyUnited States9,559,142USD0001213900-20-007650
    FY 2018Yearly · 2018-12-31ProductFirst Defense Product Line10,663,265USD0001213900-20-007650
    FY 2018Yearly · 2018-12-31ProductOther Animal Health298,932USD0001213900-20-007650
    FY 2018Yearly · 2018-12-31ProductOther Product Services24,100USD0001213900-20-007650
    FY 2017Yearly · 2017-12-31ProductFirst Defense Product Line9,814,501USD0001213900-19-004653
    FY 2017Yearly · 2017-12-31ProductOther Animal Health423,790USD0001213900-19-004653
    FY 2017Yearly · 2017-12-31ProductOther Product Services192,800USD0001213900-19-004653

    Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.